One necessary active pharmaceutical ingredient (API) is rivaroxaban. Pharmaceutical businesses must choose reliable rivaroxaban API manufacturers. Strict regulatory requirements must be met by these firms. Additionally, they must exhibit dependable supply chains and constant quality. For formulation scientists, procurement managers, and regulatory affairs specialists, this handbook offers a thorough insight. It discusses the technical features, uses, and major international providers of the API.
An overview of the API for Rivaroxaban
Rivaroxaban is an anticoagulant that is taken orally. Its main function in tablet formulations is as an active pharmaceutical ingredient. Pharmaceutical companies use it to create drugs that treat and prevent blood clots. Rivaroxaban’s chemical identification is accurate.
– Number of CAS: 366789-02-8
– Formula for the molecule: C19H18ClN3O5S
– Category of Treatment: Anticoagulant
It works well as a direct inhibitor of Factor Xa because of its unique structure. It is therefore a necessary part of contemporary antithrombotic treatments. Its creation represented a major improvement over earlier anticoagulants. It provides a pharmacologic profile that is more predictable.
The way that Rivaroxaban API works
Factor Xa is directly inhibited by rivaroxaban. Its therapeutic impact is largely dependent on this activity. A necessary part of the blood coagulation cascade is factor Xa. It is located where the extrinsic and intrinsic routes merge.
Rivaroxaban inhibits the action of Factor Xa by binding to it. This inhibitor stops prothrombin from becoming thrombin. The last enzyme in the clotting cascade is thrombin. It is in charge of turning fibrinogen into fibrin. The mesh that makes up a blood clot is made of fibrin.
Thrombin production is considerably decreased by Factor Xa suppression. Consequently, it effectively reduces the body’s capacity to produce thrombi. The activity of rivaroxaban is quite selective. It can function without a cofactor such as antithrombin. Its good safety profile and predictable anticoagulant response are facilitated by this selectivity. For the majority of patients, the mechanism eliminates the need for regular coagulation monitoring.
Uses for the Rivaroxaban API
Rivaroxaban API’s distinct mechanism makes it useful in a number of clinical settings. The API is used by pharmaceutical formulators to create oral tablets. Several thromboembolic conditions are treated by these tablets.
Important uses consist of:
Stroke Prevention: It is frequently used to stop strokes and systemic emboli. Patients with non-valvular atrial fibrillation are affected by this. An increased risk of cardiac clot development is associated with atrial fibrillation.
Rivaroxaban is recommended for the treatment of deep vein thrombosis (DVT). Blood clots in deep veins, typically in the legs, are a symptom of DVT.
It is also utilized in the treatment of pulmonary embolism (PE). A PE happens when a fragment of a DVT clot breaks off and enters the lungs.
Recurrence Prevention: Following first treatment, rivaroxaban can prevent the recurrence of PE and DVT.
Postoperative Prophylaxis: It works well for preventing thrombosis following significant orthopedic procedures. This includes surgery to replace a hip or knee. There is a significant risk of postoperative clot development with these procedures.
Principal Producers of Rivaroxaban APIs
Numerous well-known rivaroxaban API manufacturers compete on the international market. These businesses are renowned for their strong manufacturing procedures, regulatory compliance, and quality. They are significant rivaroxaban API suppliers and exporters.
Cambrex: This business specializes in manufacturing that complies with cGMP. Cambrex successfully negotiates international regulatory standards. They offer dependable APIs for the creation of pharmaceuticals.
Doctor Reddy’s Labs: A significant participant with cutting-edge R&D skills. At Dr. Reddy’s, regulatory compliance is a top priority. They make sure their APIs adhere to strict global standards.
Worldwide Calcium: Both USDMF and EU-GMP certifications are held by this firm. Global Calcium provides comprehensive support for documentation. For applications involving generic drugs, this is necessary.
AR Life Sciences: High-quality intermediates and API development are the supplier’s areas of expertise. AR Life Sciences places a strong emphasis on production that is guided by science. They guarantee uniformity and purity.
Production Guidelines for Rivaroxaban API Producers
Strict international standards must be followed for manufacturing rivaroxaban API. The final drug product’s quality, safety, and effectiveness are guaranteed by these rules. Reputable suppliers of rivaroxaban API in bulk need to prove compliance in a number of important areas.
First, the cornerstone is Current Good Manufacturing Practices (cGMP). These practices govern the design, oversight, and management of industrial facilities and processes. Adhering to cGMP ensures the identity, strength, quality, and purity of the API.
Second, market access requires certain credentials.
The U.S. Drug Master File, or USDMF: This FDA application includes private, comprehensive details regarding the API. As part of a drug application, it enables the FDA to examine the API.
The EDQM issues a Certificate of Suitability (CEP). In Europe, it streamlines the market authorization procedure.
EU-GMP: The manufacturer’s compliance with European Good Manufacturing Practices is attested by this certification.
Manufacturers also need to create non-patent-infringing procedures. This is particularly important while creating generic rivaroxaban API. A secure supply chain and a dependable quality assurance system are also necessary. These components guarantee a steady supply for the manufacturing of pharmaceuticals and guard against contamination.
Features and Technical Details of the Rivaroxaban API
Formulators and engineers need to be aware of the intricate technical details of the rivaroxaban API. These factors affect everything from the creation of the formulation to the functionality of the finished dosage form.
|
Specification |
Details |
|
Chemical Name |
5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide |
|
CAS Number |
366789-02-8 |
|
Molecular Formula |
C19H18ClN3O5S |
|
Molecular Weight |
435.9 g/mol |
|
Appearance |
White to off-white crystalline powder |
|
Solubility |
Practically insoluble in water. Soluble in DMSO and slightly soluble in acetone. |
|
Melting Point |
Approximately 228-230 °C |
|
Purity (by HPLC) |
Typically ≥ 99.0% |
|
Dosage Forms |
Primarily formulated into oral solid tablets |
|
Available Strengths |
2.5 mg, 10 mg, 15 mg, 20 mg |
|
Pharmacokinetics |
Absorption: Well-absorbed with high bioavailability. |
|
Related Intermediates |
5-chlorothiophene-2-carboxylic acid (CAS 24065-33-6), |
Questions and Answers (FAQs)
What is the Rivaroxaban API’s main purpose?
It is utilized in the production of oral drugs that treat and prevent stroke, pulmonary embolism, and deep vein thrombosis (DVT) in individuals with non-valvular atrial fibrillation.
Which companies are the main producers of Rivaroxaban API?
Among the top producers are AR Life Sciences, Global Calcium, Dr. Reddy’s Laboratories, and Cambrex.
Which certifications are necessary for the production of Rivaroxaban API?
A U.S. Drug Master File (USDMF), a Certificate of Suitability (CEP), EU-GMP certification, and cGMP compliance are all necessary certifications.
What is Rivaroxaban’s method of action?
It inhibits Factor Xa in a direct and specific manner. By stopping the blood coagulation cascade, this action lowers the production of thrombin and the resulting formation of a clot.
Which dose variants of Rivaroxaban API are available?
It is mostly made into solid oral pills. 2.5 mg, 10 mg, 15 mg, and 20 mg are typical strengths.
